Polymorphism of the apolipoprotein B gene and blood lipid concentrations in Japanese and Caucasian population samples

Atherosclerosis

Volumn 126, Issue 2, 1996, Pages 233-241

  Iso, Hiroyasu ^a   Harada, Shoji ^a   Shimamoto, Takashi ^a   Folsom, Aaron R ^b   Koike, Kazuko ^c   Sato, Shinichi ^d   Iida, Minoru ^d   Komachi, Yoshio ^e  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF MINNESOTA   (United States)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e Osaka Prefectural Suita Public Health Center   (Japan)

Author keywords

Apo B gene; Blood total cholesteroI; Coronary risk factors; Cross cultural comparison; Polymorphism

Indexed keywords

APOLIPOPROTEIN B;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RURAL AREA; URBAN AREA;

EID: 0030601632     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05912-6     Document Type: Article

References (49)

1. Keys A. Summary: coronary heart disease in seven countries. Circulation. 42((Suppl I)):1970;186-198.
2. Keys A. The diet: coronary heart disease in seven countries. Circulation. 42((Suppl I)):1970;162-183.
3. International Collaborative Study Group. Metabolic epidemiology of plasma cholesterol within populations and between populations. Lancet 1986;2:991-995.
4. Kagan A, Harris BR, Winkelstein W Jret al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: demographic, physical, dietary and biochemical characteristics. J Chron Dis. 27:1974;345-364.
5. Blakhart BD, Ludwig EM, Pierotti VRet al. Structure of the human apolipoprotein B gene. J Biol Chem. 261:1986;15364-15367.
6. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA. 86:1989;587-591.
7. Bersot TP, Russell SJ, Thatcher SRet al. A unique hapolotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J Lipid Res. 34:1993;1149-1154.
8. Berg K DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet. 30:1986;515-520.
9. Law A, Powell LM, Brunt Het al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1:1986;1301-1303.
10. Talmud PJ, Barni N, Kessling AMet al. Apoliprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 67:1987;81-89.
11. Peacook R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young mycardinal infarction survivors and healthy population-based individuals. Atherosclerosis. 92:1992;151-164.
12. Bohn M, Bakken A, Erikssen J, Berg K XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clin Genet. 44:1993;241-248.
13. Hansen PS, Klausen IC, Lemming L, Gerdes LU, Gregersen N, Faergeman O Apolipoprotein B gene polymorphisms in ischemic heart disease and hypercholesterolemia: effects of age and sex. Clin Genet. 45:1994;78-83.
14. Hegele RA, Huang LS, Herbert PNet al. Apolipoprotein B-gene DNA polymorphisms associated with myocardial information. New Engl J Med. 315:1986;1509-1515.
15. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D, Humphries SE Restriction fragment length polymorphisms in the Apo B gene in relation to coronary artery disease. Atherosclerosis. 77:1989;193-201.
16. Darnfors C, Wiklund O, Nilsson Jet al. Lack of correlation between the apolipoprotein B XbaI polymorphism and blood lipid levels in a Swedish population. Atherosclerosis. 75:1989;183-188.
17. Carlsson P, Darnfors C, Olofsson S-O, Bjunsell G Analysis of the human apolipoprotein B gene: complete structure of the B-74 region. Gene. 49:1986;29-34.
18. Demant T, Houlston RS, Caslake MJet al. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein gene. J Clin Invest. 82:1988;797-802.
19. Houlston RS, Turner PR, Lewis B, Humphries SE Genetic epidemiology of differences in low-density lipoprotein (LDL) cholesterol concentration: possible involvement of variation at the apolipoprotein B gene locus in LDL kinetics. Genet Epidemiol. 7:1990;199-210.
20. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Humphries SE Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in Dane. Atherosclerosis. 89:1991;69-81.
21. Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harbor Symp Quant Biol. 51:1986;403-409.
22. Paulweber R, Friedl W, Krempler F, Humphries SE, Sandhofer F Association of DNA polymorphism at the Apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis. 10:1990;17-24.
23. Genest JJ Jr., Ordovas JM, McNamara JRet al. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis. 82:1990;7-17.
24. Saha N, Tong MC, Tay JSH, Jeyaseelan K, Humphries SE DNA polymorphisms of the apolipoprotein B gene in Chinese coronary heart disease patients. Clin Genet. 42:1992;164-170.
25. Aburatani H, Murase T, Takaku F, Itoh H, Matsumoto A, Itakura H Apolipoprotein B-gene polymorphism and myocardial infarction. New Engl J Med. 317:1987;52.
26. Aburatani H, Matsumoto A, Itoh Het al. A study of DNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis. 72:1988;71-76.
27. Knott TJ, Rall SC Jr., Innerarity TLet al. Human apoliopoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science. 230:1985;37-43.
28. Humphries SE DNA polymorphisms of the apolipoprotein genes - their use in the investigation of the genetic component of hyperlipidemia and atherosclerosis. Atherosclerosis. 72:1988;89-108.
29. Rajput-Williams J, Knott TJ, Wallis SCet al. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 2:1988;1442-1446.
30. De Benedictis G, Rose G, Mazzei Ret al. EcoRI-RFLP of the Apo B gene: a study in a sample group from South Italy. Ann Hum Genet. 55:1991;103-113.
31. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989:129;687-702.
32. Shimamoto T, Komachi Y, Inada Het al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation. 79:1989;503-515.
33. Iso H, Folsom AR, Sato Set al. Plasma fibrinogen and its correlates in US and Japanese population samples. Arterios Thromb. 13:1993;783-790.
34. Meade TW, Imerson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet 1987;ii:986-88.
35. Goldbourt U, Medalie JH Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics Am J Epidemiol. 105:1977;75-86.
36. National Heart, Lung and Blood Institute. ARIC Manuals of Operations: 7. Blood Collection and Processing; 8. Lipid and Lipoprotein Determination; 9. Hemostasis Determinations. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina.
37. Nagele U, Hagele EO, Sauer Get al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Biochem. 22:1984;165-174.
38. Manual of Laboratory Operations, Lipid Research Clinics Program: lipid and lipoprotein analysis. Bethesda, MD, US: Department of Health and Welfare Publication 1974;1:75-628.
39. Nakamura M, Morita M, Yabuuchi Eet al. The evaluation and the results of cooperative cholesterol and triglyceride standardization program by WHO-CDC. Rinsho Byori. 30:1982;325-332. (in Japanese).
40. Warnick GR, Benderson JM, Albers JJ Quantization of high-density-lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. Clin Chem. 28:1982;1574. (Abstract).
41. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
42. Cloey T, Bachorik PS, Becker D, Finney C, Lowry D, Sigmund W. Reevaluation of serum-plasma differences in total cholesterol concentrations. JAMA 1990;263:2788-89.
43. Owan I, Suda T Strategy of osteoporosis therapy (in Japanese). J Clin Exp Med (Igaku no Ayumi). 160:1992;115-117.
44. The Ministry of Health and Welfare. A report of National Survey on Circulatory Disorders 1990. Tokyo: Cardiovascular Disease Research Foundation 1993 (in Japanese, English abstract).
45. Johnson CL, Rifkind BM, Sempos CTet al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA. 269:1993;3002-3008.
46. Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian decent. Atherosclerosis. 91:1991;267-275.
47. Saha N, Tay JSH, Heng CK, Humphries SE DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet. 44:1993;113-120.
48. Saha N, Tay JSH, Humphries SE Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI), serum lipids, and apolipoproteins in healthy Chinese. Genet Epidemiol. 9:1992;1-10.
49. Beaumont JL, Carlson LA, Cooper GB, Fejfar Z, Frederickson DS, Strasser J Classification of hyperlipidemia and hyperlipoproteinaemias. Bull WHO. 43:1970;891-915.